Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Somatostatin

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 481,019Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ITM Reveals Higher Response Rates Of (ITM-11) Vs. Everolimus
    ITM Reveals Higher Response Rates Of (ITM-11) Vs. Everolimus

    25 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/25/3174139/0/en/ITM-Announces-Analyses-from-Phase-3-COMPETE-Data-Showing-Higher-Objective-Response-Rates-with-n-c-a-177Lu-edotreotide-ITM-11-vs-Everolimus-Across-Subgroups-of-Patients-with-GEP-NET.html

    GLOBENEWSWIRE
    25 Oct 2025
    Share Share
    Results from Amyrt’s Phase 3 Trial of Mycapssa Published in The Lancet
    Results from Amyrt’s Phase 3 Trial of Mycapssa Published in The Lancet

    04 Jan 2022

    // TRIALSITENEWS

    https://trialsitenews.com/results-from-amyrt-pharmas-phase-3-mpowered-trial-of-mycapssa-oral-octreotide-for-acromegaly-published-in-the-lancet-diabetes-endocrinology/

    TRIALSITENEWS
    04 Jan 2022
    Share Share
    A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino
    A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino

    16 Jul 2018

    // John Carroll ENDPTS

    https://endpts.com/a-unicorn-joins-this-weeks-stampede-of-biotechs-into-the-red-hot-nasdaq-casino/

    John Carroll ENDPTS
    16 Jul 2018
    Share Share